These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Optimal waist circumference cutoff value for defining the metabolic syndrome in postmenopausal Latin American women. Blümel JE; Legorreta D; Chedraui P; Ayala F; Bencosme A; Danckers L; Lange D; Espinoza MT; Gomez G; Grandia E; Izaguirre H; Manriquez V; Martino M; Navarro D; Ojeda E; Onatra W; Pozzo E; Prada M; Royer M; Saavedra JM; Sayegh F; Tserotas K; Vallejo MS; Zuñiga C; Menopause; 2012 Apr; 19(4):433-7. PubMed ID: 22067278 [TBL] [Abstract][Full Text] [Related]
23. Insomnia in women approaching menopause: Beyond perception. Baker FC; Willoughby AR; Sassoon SA; Colrain IM; de Zambotti M Psychoneuroendocrinology; 2015 Oct; 60():96-104. PubMed ID: 26142241 [TBL] [Abstract][Full Text] [Related]
24. Age of menopause and impact of climacteric symptoms by geographical region. Palacios S; Henderson VW; Siseles N; Tan D; Villaseca P Climacteric; 2010 Oct; 13(5):419-28. PubMed ID: 20690868 [TBL] [Abstract][Full Text] [Related]
25. The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III): prevalence of the metabolic syndrome in postmenopausal Latin American women. Royer M; Castelo-Branco C; Blümel JE; Chedraui PA; Danckers L; Bencosme A; Navarro D; Vallejo S; Espinoza MT; Gómez G; Izaguirre H; Ayala F; Martino M; Ojeda E; Onatra W; Saavedra J; Tserotas K; Pozzo E; Manriquez V; Prada M; Grandia E; Zuniga C; Lange D; Sayegh F; Climacteric; 2007 Apr; 10(2):164-70. PubMed ID: 17453865 [TBL] [Abstract][Full Text] [Related]
26. Burden associated with chronic sleep maintenance insomnia characterized by nighttime awakenings among women with menopausal symptoms. Bolge SC; Balkrishnan R; Kannan H; Seal B; Drake CL Menopause; 2010; 17(1):80-6. PubMed ID: 19730276 [TBL] [Abstract][Full Text] [Related]
28. Sleep and menopause. Landis CA; Moe KE Nurs Clin North Am; 2004 Mar; 39(1):97-115. PubMed ID: 15062730 [TBL] [Abstract][Full Text] [Related]
29. Attitudes to the prescription of menopause hormone therapy for vasomotor symptoms and osteoporosis for patients of different ages: A survey of gynecologists in Belgium. Rozenberg S; Vandromme J Maturitas; 2019 Oct; 128():60-63. PubMed ID: 31561825 [TBL] [Abstract][Full Text] [Related]
30. [The risks of avoiding hormone replacement therapy during menopause]. Blümel JE; Arteaga E Rev Med Chil; 2017 Jun; 145(6):760-764. PubMed ID: 29171625 [No Abstract] [Full Text] [Related]
32. The association of depression status with menopause symptoms among rural midlife women in China. Zang H; He L; Chen Y; Ge J; Yao Y Afr Health Sci; 2016 Mar; 16(1):97-104. PubMed ID: 27358619 [TBL] [Abstract][Full Text] [Related]
33. Prevalence of insomnia and related factors in a large mid-aged female Colombian sample. Monterrosa-Castro A; Marrugo-Flórez M; Romero-Pérez I; Chedraui P; Fernández-Alonso AM; Pérez-López FR Maturitas; 2013 Apr; 74(4):346-51. PubMed ID: 23391501 [TBL] [Abstract][Full Text] [Related]
34. Changes of the prescription of hormone therapy in menopausal women: an observational study in Taiwan. Huang WF; Tsai YW; Hsiao FY; Liu WC BMC Public Health; 2007 Apr; 7():56. PubMed ID: 17439639 [TBL] [Abstract][Full Text] [Related]
35. [Psychosocial and socioeconomic factors related to insomnia and menopause: Pró-Saúde Study]. Robaina JR; Lopes CS; Rotenberg L; Faerstein E Cad Saude Publica; 2015 Mar; 31(3):597-606. PubMed ID: 25859726 [TBL] [Abstract][Full Text] [Related]
36. The prevalence of metabolic syndrome in Latin America: a systematic review. Márquez-Sandoval F; Macedo-Ojeda G; Viramontes-Hörner D; Fernández Ballart JD; Salas Salvadó J; Vizmanos B Public Health Nutr; 2011 Oct; 14(10):1702-13. PubMed ID: 21486521 [TBL] [Abstract][Full Text] [Related]
37. [Survey on epidemiologic factors associated with the age of natural menopause and menopausal symptoms in Jiangsu women]. Li L; Wu J; Jiang XQ; Pu DH; Zhao Y Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):728-33. PubMed ID: 24406127 [TBL] [Abstract][Full Text] [Related]
38. [Prevalence of metabolic syndrome and its components in the menopausal transition: a systematic review]. Mendes KG; Theodoro H; Rodrigues AD; Olinto MT Cad Saude Publica; 2012 Aug; 28(8):1423-37. PubMed ID: 22892963 [TBL] [Abstract][Full Text] [Related]
39. Prevalence of vasomotor, psychological, psychosomatic and sexual symptoms in perimenopausal and recently postmenopausal Greek women: association with demographic, life-style and hormonal factors. Grigoriou V; Augoulea A; Armeni E; Rizos D; Alexandrou A; Dendrinos S; Panoulis K; Lambrinoudaki I Gynecol Endocrinol; 2013 Feb; 29(2):125-8. PubMed ID: 22849709 [TBL] [Abstract][Full Text] [Related]
40. Treatment of climacteric symptoms in Finland prior to the controversial reports on hormone therapy. Jalava-Broman J; Mäkinen J; Ojanlatva A; Jokinen K; Sillanmäki L; Rautava P Acta Obstet Gynecol Scand; 2008; 87(6):682-6. PubMed ID: 18568469 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]